Contact us to find out if we have the data you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple language support. Please visit our Contact page to see which office is open right now!

The research services deals with the a strategic insight in to the opportunity in the drug delivery markets especially pulmonary and transdermal segments in Europe. Market more…

The report "Booming Biotech Market in India" by RNCOS provides an exhaustive overview of the biotechnology market in India. It provides a detailed account of the factors that more…

The tissue implant market is vast, competitive and high-growth sector. It covers human tissue products and products derived from human tissue. The products are purely tissue more…

Over the last decade, the drug delivery industry has evolved to become a key area in the development of value added pharmaceutical products. The global market grew from $15bn more…

This research service analyes the market opportunities for POC connectivity solutions in major seven European countries like Germany, France, Italy, Spain, UK, Benelux and more…

Abstract Overview Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 more…

This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue more…

Introduction Diagnostics can be used to identify subgroups of patients who may or may not benefi t from a companion drug, who may have adverse reactions to that drug, or who more…

Executive Summary This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug more…

The Clinical Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the clinical stage agreements entered into by the more…

This market snapshot global research service looked at the Membrane Bioreactor systems market in Europe, North & South America, Asia Pacific, Middle East and Africa. A more…

This report analyzes the prevalent stem cell technologies and the therapeutic areas in which stem cells find their applications. The study provides a market insight into the more…

Introduction Demographic and cost data provide clear reasons for pharmaceutical industry investment in CVD biomarkers and diagnostics. CVDs are highly prevalent and more…

Decreasing oil production from almost all the oil reserves is attracting the world's eyes towards renewable energy sources. Rising energy consumption and environmental issues more…

This completely updated edition of Kalorama's comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market more…

Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on more…

This report provides extensive competitive comparison and evaluation of major and emerging companies in the orthobiologics market covering key sectors: alllograft tissue, more…

This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market more…

This research service gives a detailed analysis of the NAT reagents market for clinical applications in Europe from 2004-2014 more…

Topics covered include: Strategies to develop small- and large-mol-ecule CNS drugs capable of crossing the blood-brain barrier (BBB) Interviews with leading researchers who ar more…

At least 50 companies have a claimed product or service relevant to cardiotoxicity screening, of which 29 have some clear focus on proarrhythmic cardiotoxicity or ion channel more…

This is the latest Epigenetics and MicroRNA Diagnostics/Therapeutics Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the more…

Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research more…

This report focuses on the current and future applications of Systems Biology in drug discovery, specifically in pinpointing optimal individual targets, and combinations of more…

This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe. It includes technology trends, challenges, drivers, more…

The Manufacturing and Supply Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered more…

Executive Summary The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of more…

Executive Summary Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new more…

Executive Summary Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug more…

Executive Summary Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. more…

2007 Industry Financials, including 12 months of company financial data and market caps for the US, Europe, Canada, and Asia Analysis of key activities across industry sectors more…

In recent years, there have been concerted efforts to enhance the precision of disease diagnosis and monitoring as the hetrogeneity of conditions becomes increasingly more…

Fuji-Keizai U.S.A. published a market research report on the biochip business in August 2006. Since that early report, more than 18 months have passed and the biochip business more…

The Distribution Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the more…

Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales. To achieve commercial success, in vitro more…

Worldwide interest in biogenerics or biosimilars is gaining momentum. Since Kalorama Information last visited the market for synthetic or recombinant versions of natural more…

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early more…

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that more…

The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines more…

Introduction The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs. Targeted biologics utilizing more…

This research service provides the latest trends in apoptosis research and future developments more…

Biogen Idec is a global research-based company focused on the development, manufacture and commercialisation of novel therapeutics for human health care. This new strategic more…

This market insight report on Chiral Chemicals focuses on the different Methods and Applications of Chiral Chemicals. Various Chiral Chemical preparation and separation more…

Global demand to approach 90 million metric tons in 2011 Demand for biofuels will expand almost 20 percent per year through 2011 to 92 million metric tons, despite recent more…

This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective. more…

Demand to grow more than 10% annually through 2012 US demand for drug delivery systems is projected to expand more than ten percent annually to $132 billion in 2012. Growth more…

Overview Introduction Antibody-based agents represent a novel approach to the treatment and prophylaxis of infectious diseases. In recent years, considerable interest has been more…

This research service analyzes the market for cell-based assays within the United States. This market was divided into three segments, covering cell growth-associated assays, more…

Overview Introduction SLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares. Therapy is large more…

Introduction Pharmacogenomics (PGx) is an evolutionary-not a revolutionary-process. The "blockbuster" business model is, of course, still relevant to the pharmaceutical more…

Introduction Monoclonal antibodies (MAbs) are very hot commodities in today's pharmaceutical marketplace, and in recent years, the growth in the number of MAbs under more…

Microelectronics, which has led to the explosion of consumer electronics sales, could now bring its added value to the Life Science applications. The key challenge for more…

With the first diagnostics set to debut within a year, the new research and development field of microRNAs is beginning to reveal its potential. This new report establishes a more…

By now we all know that "the paperless office" of the future is still just that -- "of the future." Nevertheless, more life science products are being shopped for and more…

This research service analyzes the market for research ELISAs within the United States. The market was divided into the research ELISA kit and research ELISA development more…

In recent years, the maximization of blockbuster revenues has been compromised by generic price erosion and a decline in new drug approvals. Large pharmaceutical companies are more…

This research service studies the blood gas analysers and monitors market in Eastern Europe with qualitative and quantitative perspective. The systems covered in this study more…

This Frost & Sullivan research service titled Strategic Analysis of the Chinese Biofuel Market provides an overview of the Chinese biofuel market size and structure as a more…

Report description The Bigpharma Partnering Agreements provides comprehensive and unprecedented access to the partnering agreements entered into by the worlds leading fifty more…

Most comprehensive report covering worldwide markets more…

Most comprehensive report covering worldwide markets more…

This is the most comprehensive report covering worldwide markets of Laboratory Chemical Reagents more…

This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive more…

This report analyzes the worldwide markets for Organ And Tissue Transplantation by Number of Procedures. The specific product segments analyzed for the global and other more…

This is the most comprehensive report covering worldwide market of seeds more…

Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, more…

The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and more…

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies more…

In recent years, the biopharmaceutical industry has emerged as one of the most important sectors in the Healthcare industry. Advances in life sciences have resulted in the more…

You have a solid relationship with a client and your products are integral to their research program. But one day you notice sales dropping and wonder why your calls not being more…

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercialises ethical drugs. This report provides a full review of the company’s activities more…

Introduction Validating a biomarker is a resource-intensive undertaking. Is it worth it? We say, Yes. A biomarker that wins "known validated" status is best positioned for more…

This market insight report presents an in depth analysis of DNA Sequencing market. The study emphasizes on the Methods of DNA Sequencing and Instruments/Software used in DNA more…

This research service examines the European market for biopsy devices in terms of the challenges faced by market participants, drivers, and restraints in the industry, the more…

Author: Olivia Scaros, PharmD The development and growth of assay technologies has pushed translational medicine into a category unto itself. In a broad perspective on this more…